About FYR Diagnostics
FYR Diagnostics is a company based in Missoula (United States) founded in 2016.. FYR Diagnostics has raised $8 million across 4 funding rounds from investors including HHS and America’s Seed Fund. FYR Diagnostics offers products and services including Liquid Biopsy Solutions and Sequencing Services. FYR Diagnostics operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
- Headquarter Missoula, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8 M (USD)
in 4 rounds
-
Latest Funding Round
$8 M (USD), Series A
Aug 02, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FYR Diagnostics
FYR Diagnostics offers a comprehensive portfolio of products and services, including Liquid Biopsy Solutions and Sequencing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops tools using EVs for detecting disease biomarkers in healthcare.
Offers high-quality next-generation sequencing for clinical and research needs.
Unlock access to complete
Leadership Team
2 people
Product Management Team
2 people
Junior Team
1 people
Operations Team
1 people
Unlock access to complete
Funding Insights of FYR Diagnostics
FYR Diagnostics has successfully raised a total of $8M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $8.0M
-
First Round
First Round
(01 Sep 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - FYR Diagnostics | Valuation |
investors |
|
| Aug, 2021 | Amount | Grant - FYR Diagnostics | Valuation |
investors |
|
| Dec, 2020 | Amount | Grant - FYR Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in FYR Diagnostics
FYR Diagnostics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by FYR Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - FYR Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fyr Diagnostics Comparisons
Competitors of FYR Diagnostics
FYR Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| domain | founded_year | HQ Location |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fyr Diagnostics
Frequently Asked Questions about FYR Diagnostics
When was FYR Diagnostics founded?
FYR Diagnostics was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is FYR Diagnostics located?
FYR Diagnostics is headquartered in Missoula, United States. It is registered at Missoula, Montana, United States.
Is FYR Diagnostics a funded company?
FYR Diagnostics is a funded company, having raised a total of $8M across 4 funding rounds to date. The company's 1st funding round was a Grant of $256K, raised on Sep 01, 2019.
What does FYR Diagnostics do?
FYR Diagnostics was founded in 2016 in Missoula, United States, within the healthcare and diagnostics sector. In-vitro diagnostic tests are offered for disease detection in humans and agriculture. A portfolio of biomarker detection technologies is developed, emphasizing nucleic acid amplification methods. These technologies support accelerated prediction, diagnosis, and management of diseases through laboratory-based operations.
Who are the top competitors of FYR Diagnostics?
FYR Diagnostics's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.
What products or services does FYR Diagnostics offer?
FYR Diagnostics offers Liquid Biopsy Solutions and Sequencing Services.
Who are FYR Diagnostics's investors?
FYR Diagnostics has 2 investors. Key investors include HHS, and America’s Seed Fund.